These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33570905)

  • 61. Does the protein corona take over the selectivity of molecularly imprinted nanoparticles? The biological challenges to recognition.
    Capriotti A; Piovesana S; Zenezini Chiozzi R; Montone CM; Bossi AM; Laganà A
    J Proteomics; 2020 May; 219():103736. PubMed ID: 32198073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Measurements of heterogeneity in proteomics analysis of the nanoparticle protein corona across core facilities.
    Ashkarran AA; Gharibi H; Voke E; Landry MP; Saei AA; Mahmoudi M
    Nat Commun; 2022 Nov; 13(1):6610. PubMed ID: 36329043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions.
    Kokkinopoulou M; Simon J; Landfester K; Mailänder V; Lieberwirth I
    Nanoscale; 2017 Jun; 9(25):8858-8870. PubMed ID: 28632260
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Size, Shape, and Protein Corona Determine Cellular Uptake and Removal Mechanisms of Gold Nanoparticles.
    Ding L; Yao C; Yin X; Li C; Huang Y; Wu M; Wang B; Guo X; Wang Y; Wu M
    Small; 2018 Oct; 14(42):e1801451. PubMed ID: 30239120
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches.
    Papa E; Doucet JP; Sangion A; Doucet-Panaye A
    SAR QSAR Environ Res; 2016 Jul; 27(7):521-38. PubMed ID: 27329717
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
    Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
    ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Experimental separation steps influence the protein content of corona around mesoporous silica nanoparticles.
    Pisani C; Gaillard JC; Dorandeu C; Charnay C; Guari Y; Chopineau J; Devoisselle JM; Armengaud J; Prat O
    Nanoscale; 2017 May; 9(18):5769-5772. PubMed ID: 28429028
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An improved protocol for ICP-MS-based assessment of the cellular uptake of metal-based nanoparticles.
    Kruszewska J; Kur A; Kulpińska D; Grabowska-Jadach I; Matczuk M; Keppler BK; Timerbaev AR; Jarosz M
    J Pharm Biomed Anal; 2019 Sep; 174():300-304. PubMed ID: 31195318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
    Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
    Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Protein Corona Conundrum: Exploring the Advantages and Drawbacks of its Presence around Amphiphilic Nanoparticles.
    de Castro CE; Panico K; Stangherlin LM; Ribeiro CAS; da Silva MCC; Carneiro-Ramos MS; Dal-Bó AG; Giacomelli FC
    Bioconjug Chem; 2020 Nov; 31(11):2638-2647. PubMed ID: 33169610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
    Thipe VC; Panjtan Amiri K; Bloebaum P; Raphael Karikachery A; Khoobchandani M; Katti KK; Jurisson SS; Katti KV
    Int J Nanomedicine; 2019; 14():4413-4428. PubMed ID: 31417252
    [No Abstract]   [Full Text] [Related]  

  • 72. Concentration and composition of the protein corona as a function of incubation time and serum concentration: an automated approach to the protein corona.
    Poulsen KM; Payne CK
    Anal Bioanal Chem; 2022 Oct; 414(24):7265-7275. PubMed ID: 36018335
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Probing the modulated formation of gold nanoparticles-beta-lactoglobulin corona complexes and their applications.
    Yang J; Wang B; You Y; Chang WJ; Tang K; Wang YC; Zhang W; Ding F; Gunasekaran S
    Nanoscale; 2017 Nov; 9(45):17758-17769. PubMed ID: 28869274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake.
    Schöttler S; Klein K; Landfester K; Mailänder V
    Nanoscale; 2016 Mar; 8(10):5526-36. PubMed ID: 26804616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein Corona Modulates Uptake and Toxicity of Nanoceria via Clathrin-Mediated Endocytosis.
    Mazzolini J; Weber RJ; Chen HS; Khan A; Guggenheim E; Shaw RK; Chipman JK; Viant MR; Rappoport JZ
    Biol Bull; 2016 Aug; 231(1):40-60. PubMed ID: 27638694
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells.
    Pisani C; Rascol E; Dorandeu C; Gaillard JC; Charnay C; Guari Y; Chopineau J; Armengaud J; Devoisselle JM; Prat O
    PLoS One; 2017; 12(8):e0182906. PubMed ID: 28796831
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicolor Super-Resolution Microscopy of Protein Corona on Single Nanoparticles.
    Wang Y; Soto Rodriguez PED; Woythe L; Sánchez S; Samitier J; Zijlstra P; Albertazzi L
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37345-37355. PubMed ID: 35961006
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.
    Cifuentes-Rius A; de Puig H; Kah JC; Borros S; Hamad-Schifferli K
    ACS Nano; 2013 Nov; 7(11):10066-74. PubMed ID: 24128271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona.
    Zhang H; Wu T; Yu W; Ruan S; He Q; Gao H
    ACS Appl Mater Interfaces; 2018 Mar; 10(10):9094-9103. PubMed ID: 29473734
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
    Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
    ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.